Fulvestrant

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

InformationFulvestrant (ICI-182780, ZD 9238, ZM 182780) is anestrogen receptor (ER)antagonist withIC50of 0.94 nM in a cell-free assay. Fulvestrant also inducesautophagyandapoptosisand has antitumor activity.In vitroFulvestrant is an effective

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

A potent ER antagonist that works by both down-regulating and degrading ER&alpha efficacious in the treatment of estrogen-sensitive breast cancer fully activates ER on hippocampal neurons.